Table 1 Summary of the included studies
Study | year | country | age | Sex (M/ F) | Sample | Illness day | diagnosis | NS1 diagnosis | ||
|---|---|---|---|---|---|---|---|---|---|---|
DF | DHF | Control | ||||||||
Hermann [8] | 2014 | Thailand | 4–12 | 152/182 | 159 | 141 | 20 | 1–7 | RT-PCR/ELISA | ELISA(Bio-Rad) |
Gan [9] | 2014 | Singapore | 18–68 | 193/53 | 147 | NR | 50 | 1–14 | IgG/ELISA | ELISA(Bio-Rad) |
Naz [10] | 2014 | Pakistan | 2–65 | 96/88 | 142 | NR | 42 | 2–7 | IgG/ELISA | Strip(Bio-Rad) |
Aryati [11] | 2013 | Indonesia | NR | NR | 188 | NR | 252 | NR | VI/RT-PCR | ELISA(Panbio) |
Huang [12] | 2013 | Taiwan | 32–60 | 175/217 | 392 | NR | 50 | 1–8 | VI/RT-PCR | Strip(Bio-Rad) |
Kosasih [13] | 2013 | Indonesia | 4–53 | 142/78 | 220 | NR | 55 | 1–7 | RT-PCR/ELISA | ELISA(Bio-Rad) |
Blacksell [14] | 2012 | Thailand | NR | NR | 239 | NR | 50 | NR | RT-PCR/ELISA | ELISA(Bio-Rad) |
Watthanaworawita [15] | 2011 | Thailand | >15 | 98/64 | 72 | NR | 90 | 1–7 | RT-PCR/ELISA | ELISA(Panbio) |
Duong [16] | 2011 | Cambodia | 4–11 | 203/136 | 101 | 87 | 139 | 3–8 | VI/RT-PCR/ELISA | ELISA(Bio-Rad) |
Chuansumrit [17] | 2011 | Thailand | <18 | NR | 19 | 36 | 30 | 2–10 | VI/ ELISA | ELISA(Bio-Rad)/Strip(Bio-Rad) |
Blacksell [18] | 2011 | Sri Lanka | NR | NR | 239 | NR | 148 | NR | RT-PCR/ELISA | ELISA(Bio-Rad, panbio)/Strip(Bio-Rad) |
Fry [19] | 2011 | Vietnam | 3–15 | NR | 198 | NR | 100 | 1–4 | RT-PCR/ELISA | Strip(Bio-Rad) |
Pok [20] | 2010 | Singapore | NR | NR | 161 | NR | 160 | 1–8 | RT-PCR/ELISA | Strip(Bio-Rad) |
Hang [21] | 2009 | Vietnam | 4–42 | 62–76 | 125 | NR | 13 | 1–10 | RT-PCR/ELISA | ELISA(Panbio) |
Zainah [22] | 2009 | Malaysia | NR | NR | 100 | NR | 219 | NR | VI/RT-PCR | Strip(Bio-Rad) |
Blacksella [23] | 2008 | Vientiane | NR | NR | 38 | NR | 54 | NR | ELISA | ELISA(Panbio) |
Lapphra [24] | 2008 | Thailand | 3–52 | 132/103 | 151 | 19 | 64 | 1–5 | VI/RT-PCR/ELISA | ELISA(Bio-Rad) |
Kumarasamy [25] | 2007 | Malaysia | NR | NR | 213 | NR | 368 | NR | VI/RT-PCR | ELISA(Bio-Rad) |